Provectus Biopharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Provectus Biopharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 44% to $557,710. The net income raised on -$3,101,768 and profit margin reached -556%. Total operating expenses were $1,759,678.
Profit Margin
| 2014 | 4.17M | -10.24M | -245.14% |
|---|---|---|---|
| 2015 | 0 | -24.50M | |
| 2016 | 0 | -24.42M | |
| 2017 | 0 | -13.51M | |
| 2018 | 0 | -8.15M | |
| 2019 | 0 | -8.37M | |
| 2020 | 0 | -8.42M | |
| 2021 | 0 | -6.50M | |
| 2022 | 989.04K | -3.55M | -359.36% |
| 2023 | 557.71K | -3.10M | -556.16% |
PVCT Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 557.71K | 989.04K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.17M |
Cost of revenue | 1.69M | 63.77K | 94.12K | 315.36K | 756.36K | 685.21K | 13.72M | 24.51M | 24.65M | 12.63B |
Gross profit | -1.14M | 925.26K | -94.12K | -315.36K | -756.36K | -685.21K | -13.72M | -24.51M | -24.65M | -12.62B |
Operating exp. | ||||||||||
Research and development | 1.74M | 2.38M | 2.60M | 2.81M | 4.00M | 4.74M | 8.20M | 8.54M | 10.70M | 5.13M |
Selling and marketing | 51.39K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 1.75M | 3.39M | 4.63M | 4.93M | 6.16M | 8.02M | 13.72M | 24.51M | 24.65M | 16.81M |
Operating income | -2.90M | -3.42M | -4.67M | -4.96M | -6.29M | -8.00M | -13.72M | -24.51M | -24.65M | -12.63M |
Other income (expenses), net | -200.51K | -126.73K | -867.28K | -1.71M | -622.84K | 825K | -197.91K | 84.75K | 151.42K | 2.39M |
Income before tax | -3.10M | -3.55M | -5.53M | -6.67M | -6.92M | -8.15M | -13.51M | -24.42M | -24.50M | -10.24M |
Income tax expense | 0 | -433 | 961.70K | 1.74M | 1.45M | -825K | -407.36K | -169.50K | -302.84K | -4.78M |
Net income | -3.10M | -3.55M | -6.50M | -8.42M | -8.37M | -8.15M | -13.51M | -24.42M | -24.50M | -10.24M |
Earnings per share | ||||||||||
Basic EPS | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 | -0.1 | -0.13 | -0.05 |
Diluted EPS | -0.00 | -0.00 | -0.01 | -0.02 | -0.02 | -0.02 | -0.03 | -0.1 | -0.13 | -0.05 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |